Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Receivables: 2013-2024

Historic Receivables for CorMedix (CRMD) over the last 10 years, with Dec 2024 value amounting to $51.7 million.

  • CorMedix's Receivables rose 835.01% to $162.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $311.8 million, marking a year-over-year increase of 1618.38%. This contributed to the annual value of $51.7 million for FY2024, which is N/A change from last year.
  • As of FY2024, CorMedix's Receivables stood at $51.7 million, which was up 113,754.66% from $45,368 recorded in FY2021.
  • In the past 5 years, CorMedix's Receivables registered a high of $51.7 million during FY2024, and its lowest value of $3,357 during FY2020.
  • Moreover, its 1-year median value for Receivables was $51.7 million (2024), whereas its average is $51.7 million.
  • Data for CorMedix's Receivables shows a peak YoY spiked of 9,491.43% (in 2020) over the last 5 years.
  • CorMedix's Receivables (Yearly) stood at $3,357 in 2020, then skyrocketed by 1,251.44% to $45,368 in 2021, then reached $51.7 million in 2024.